[Latest Melasma Treatment Survey] 70% Unaware of Laser Worsening Risks, Only 23.7% Understand Optimal 8-12 Week Tranexamic Acid Regimen
Key facts
- [Latest Melasma Treatment Survey] 70% Unaware of Laser Worsening Risks, Only 23.7% Understand Optimal 8-12 Week Tranexamic Acid Regimen
- IC Clinic surveyed women aged 30-50 on melasma treatment. Results reveal significant lack of knowledge regarding laser treatment risks and recommended medication duration.
- Source: PR Times
- Date: June 12, 2026
Direct answer
IC Clinic surveyed women aged 30-50 on melasma treatment. Results reveal significant lack of knowledge regarding laser treatment risks and recommended medication duration.
- Citation
- [Latest Melasma Treatment Survey] 70% Unaware of Laser Worsening Risks, Only 23.7% Understand Optimal 8-12 Week Tranexamic Acid Regimen (June 12, 2026), PR Times
- Source
- PR Times
- Date
- June 12, 2026
IC Clinic surveyed women aged 30-50 on melasma treatment. Results reveal significant lack of knowledge regarding laser treatment risks and recommended medication duration.
📋 Article Processing Timeline
- 📰 Published: June 12, 2026 at 18:00
- 🔍 Collected: June 12, 2026 at 09:21
- 🤖 AI Analyzed: June 12, 2026 at 10:13 (52 min after Collected)
## Key Survey Findings
Melasma manifests as light brown, symmetrical patches on the cheekbones. Because standard spot-removal lasers carry a risk of exacerbating melasma, treatment based on oral tranexamic acid is recommended. Effectiveness is typically felt after 8 to 12 weeks of consistent intake, and combined use with laser toning may offer improved results.
- Unaware that laser therapy can worsen melasma: 68.3%
- Correctly understand the 8-12 week tranexamic acid regimen: 23.7%
- Confident in distinguishing melasma from standard sunspots: 18.0%
## Glossary
- Melasma (Kanpan): An acquired pigmentation disorder common in women aged 30-50, appearing as symmetrical light brown patches.
- Oral Tranexamic Acid Therapy: A treatment that inhibits melanin production using anti-plasmin effects, recommended by the Japanese Dermatological Association guidelines.
- Laser Toning: A treatment using low-output lasers to gradually reduce melanin without stimulating melanocytes, suitable for melasma.
## Survey Overview
- Target: 300 women aged 30-60 nationwide struggling with facial spots.
- Period: May 18 - May 27, 2026.
- Method: Internet survey.
Melasma manifests as light brown, symmetrical patches on the cheekbones. Because standard spot-removal lasers carry a risk of exacerbating melasma, treatment based on oral tranexamic acid is recommended. Effectiveness is typically felt after 8 to 12 weeks of consistent intake, and combined use with laser toning may offer improved results.
- Unaware that laser therapy can worsen melasma: 68.3%
- Correctly understand the 8-12 week tranexamic acid regimen: 23.7%
- Confident in distinguishing melasma from standard sunspots: 18.0%
## Glossary
- Melasma (Kanpan): An acquired pigmentation disorder common in women aged 30-50, appearing as symmetrical light brown patches.
- Oral Tranexamic Acid Therapy: A treatment that inhibits melanin production using anti-plasmin effects, recommended by the Japanese Dermatological Association guidelines.
- Laser Toning: A treatment using low-output lasers to gradually reduce melanin without stimulating melanocytes, suitable for melasma.
## Survey Overview
- Target: 300 women aged 30-60 nationwide struggling with facial spots.
- Period: May 18 - May 27, 2026.
- Method: Internet survey.
FAQ
肝斑（かんぱん）とはどのようなものですか？
30〜50代の女性に多く見られる、左右対称に頬骨に沿って現れる淡い褐色の色素沈着症です。通常のシミ取りレーザーでは悪化するリスクがあります。
肝斑治療におけるトラネキサム酸の適切な服用期間は？
効果を実感するためには8〜12週間の継続服用が推奨されています。
肝斑に通常のレーザー治療を行ってはいけない理由は？
肝斑は刺激に反応してメラニンが活性化するため、通常のシミ取りレーザーでは逆に色素沈着が悪化する危険性があるからです。
レーザートーニングとはどのような治療法ですか？
低出力のQスイッチYAGレーザーを用い、メラノサイトを刺激せずにメラニンを徐々に排出させる治療法です。肝斑にも適応可能で、内服薬との併用も推奨されます。
調査対象者のうち、レーザーによる肝斑悪化リスクを知らない人の割合は？
68.3%が、肝斑に通常のシミ取りレーザーを照射すると悪化する可能性があることを認識していませんでした。